Glasgow, Scotland - 11 November 2024. EnteroBiotix Limited ('EnteroBiotix' or the 'Company'), a clinical-stage biotechnology company focussed on developing best-in-class full-spectrum microbiome ...

Groundbreaking bone marrow transplant saves 10-month-old boy with rare genetic immunodeficiency, funded by The Hans ...

Graft-versus-host disease prophylaxis using posttransplant cyclophosphamide remains a valid option for patients with ...

In a study that identified male chromosome genetic material in the intestines of female patients undergoing fecal transplants, researchers say they have significantly expanded scientific understanding ...

"We are pleased with our operational and clinical execution this quarter and look forward to sharing additional clinical data ...

Beam Therapeutics will present new data on its sickle cell disease (SCD) therapies at the ASH meeting, including results from ...

Beam Therapeutics Inc (BEAM) reports encouraging clinical data for BEAM-101 in sickle cell treatment, while maintaining a ...

The patient died four months after BEAM-101 infusion “due to respiratory failure that was determined by the investigator to ...

Verma cautioned that more studies are needed in a larger group of female patients who receive FMT from healthy male donors to determine the extent of epithelial "engraftment" in the intestines of FMT ...

Hematopoietic stem cell transplant (HSCT) from deceased donors appears feasible, safe, and effective, according to results from one of the first patients to receive this treatment.

A new human study involving some of the longest-living survivors of hematopoietic stem cell transplants sheds light on how transplanted stem cells from donors change after engraftment and mutate ...